Understanding prostate cancer in African American men
Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Immunity and Stress (RESPOND)
This study is looking into why African American men are more likely to have aggressive prostate cancer, focusing on things like genetics, immune system responses, and social stress, and it involves gathering information from 10,000 men to better understand these factors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10668262 on NIH RePORTER |
What this research studies
This research investigates the reasons behind the higher rates of aggressive prostate cancer in African American men. It aims to identify the roles of genetic factors, immune responses, and social stressors in the development and progression of the disease. By establishing a large cohort of 10,000 African American men diagnosed with prostate cancer, the study will collect data on various influences such as lifestyle, health behaviors, and genetic predispositions. This comprehensive approach will help uncover the complex interplay of factors contributing to prostate cancer aggressiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American men who have recently been diagnosed with prostate cancer.
Not a fit: Patients who are not of African ancestry or those who do not have a diagnosis of prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and targeted interventions for prostate cancer in African American men.
How similar studies have performed: Previous research has indicated that social and biological factors significantly impact cancer outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Haiman, Christopher Alan — University of Southern California
- Study coordinator: Haiman, Christopher Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.